Related Experiment Videos
Idiopathic diabetes insipidus occurring in a patient with Turner's syndrome
The Mount Sinai Journal of Medicine, New York
|November 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2023
Metal-containing landfills as a source of antibiotic tolerance.
Environmental monitoring and assessment·2023
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2021
Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2013
Supraclavicular lymph-node recurrence of breast-cancer.
Oncology reports·2011
Minority undergraduate programs intended to increase participation in biomedical careers.
The Mount Sinai journal of medicine, New York·2012
Future of electronic health records: implications for decision support.
The Mount Sinai journal of medicine, New York·2012
AA amyloidosis: Mount Sinai experience, 1997-2012.
The Mount Sinai journal of medicine, New York·2012
Amyloid neuropathies.
The Mount Sinai journal of medicine, New York·2012
Should your family history of coronary heart disease scare you?
The Mount Sinai journal of medicine, New York·2012
Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?
The Mount Sinai journal of medicine, New York·2012
Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence.
Pharmaceuticals (Basel, Switzerland)·2026
Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026